| 46 |
Lee, K. H., Song, J. H., Kim, S. C., Han, S. R., Lee, S. -W. (2023) Real-Time Monitoring Strategies for Optimization of In Vitro Transcription and Quality Control of RNA Front. Mol. Biosci. 2023, 10: 1229246 |
|
| 45 |
Lee, K. H., Kim, S. C., Song, J. H., Han, S. R., Kim, J. H., and Lee, S. -W. (2023) Efficient circular RNA engineering by end-to-end self-targeting and splicing reaction using Tetrahymena group I intron ribozyme Mol. Ther. Nucleic Acids 2023, 33, 587-598 |
|
| 44 |
Lee, K. H., Kim, S. C., and Lee, S. -W. (2022) Pros and Cons of In Vitro Methods for Circular RNA Preparation Int. J. Mol. Sci.2022, 23, 13247 |
|
| 43 |
Kim, T. H., and Lee, S.-W. (2022) Therapeutic application of genome editing technologies in viral diseases. International Journal of Molecular Sciences 23(10): 45399. |
|
| 42 |
Kim, T. H., and Lee, S.-W. (2021) Aptamers for anti-viral therapeutics and diagnostics. International Journal of Molecular Sciences 22(8): 4168. |
|
| 41 |
Han, S. R., Lee, C. H., Im, J. Y., Kim, J. H., Kim, J. H., Kim, S. J., Cho, Y. W., Kim, E., Kim, Y., Ryu, J.-H., Ju, M. H., Jeong, J. S., and Lee, S.-W. (2021) Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement throu |
|
| 40 |
Seo, M.-J., Park, J. H., Lee, K. C., Lee, Y. J., Lee, T. S., Choi, T. H., Lee, S.-W., Kim, K. I., and Kang, J. H. (2020) Small animal PET imaging of hTERT RNA-targeted HSV1-tk gene expression with trans-splicing ribozyme. Cancer Biotherapy and Radiopharma |
|
| 39 |
Lee, C. H., Han, S. R., and Lee, S.-W. (2018) Group I intron-based therapeutics through trans-splicing reaction. Progress in Molecular Biology and Translational Science 159: 79-100. |
|
| 38 |
Lee, C. H., Han, S. R., and Lee, S.-W. (2018) Therapeutic applications of group I intron-based trans-splicing ribozymes. WIREs RNA 9(3): e1466. |
|
| 37 |
Kim, S. J., Kim, J. H., Yang, B., Jeong, J.-S., and Lee, S.-W. (2017) Specific and efficient regression of cancers harboring KRAS mutation by targeted RNA replacement. Molecular Therapy 25(2): 356-367. |
|
